Jane Wright-Mitchell - Aug 16, 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
General Counsel
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Aug 16, 2021
Transactions value $
-$59,925
Form type
4
Date filed
8/18/2021, 06:02 PM
Previous filing
Aug 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $5.08K +2.5K +80% $2.03* 5.63K Aug 16, 2021 Direct
transaction PCVX Common Stock Sale -$65K -2.5K -44.44% $26.00 3.13K Aug 16, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -2.5K -1.32% $0.00 187K Aug 16, 2021 Common Stock 2.5K $2.03 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter.